Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Impact of "Institutions for Mental Diseases" Medicaid waivers on opioid use disorder treatment: a mixed methods approach to improve utilization of Medications for Opioid Use Disorders

Award Number: K01DA061053
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 06/01/2025
PERIOD OF PERFORMANCE END DATE: 05/31/2030

Group Awards By:

View Award Description

Impact of "Institutions for Mental Diseases" Medicaid waivers on opioid use disorder treatment: a mixed methods approach to improve utilization of Medications for Opioid Use Disorders - PROJECT SUMMARY/ABSTRACT: More than 80,000 opioid overdose deaths were reported in the US in 2022. Medication for opioid use disorder (MOUD) significantly reduces the risk of hospitalization and mortality from opioid overdose, but MOUD is severely underutilized. Medicaid is the largest payer of treatment for opioid use disorder (OUD), with the potential to reach a large share of the population in need of treatment. In 2015, state Medicaid programs began to adopt the newly created Section 1115 “Institutions for Mental Diseases” (IMD) waivers. These waivers allow states to use federal funds for substance use treatment in residential facilities. To date, 33 states and the District of Columbia have adopted an IMD waiver. However, it is unclear whether waivers have an impact on MOUD use and retention. State Medicaid programs have broad discretion on services covered for substance use disorders, which may lead to significant variation in treatment across jurisdictions. A careful examination of waiver configurations to compare them across jurisdictions is needed, and this effort will be among the first. This Mentored Research Career Development Award (K01) proposes a community-engaged, mixed-methods research to (1) characterize IMD waivers and provide a detailed description of waiver features in a standardized way that allows for comparison across jurisdictions, (2) quantitatively measure the impact of IMD waivers on MOUD-based treatment and health outcomes (e.g., MOUD initiation, retention, and overdoses) using Medicaid claims, and (3) qualitatively explore waiver implementation in the first 10 jurisdictions that adopted a waiver using in-depth interviews with stakeholders engaged in state Medicaid agencies and provider networks. Mixed methods will be used to triangulate findings from the aims and provide a comprehensive picture of the waivers. The community-engaged component of this study will include an advisory board to provide ongoing input, including interpretation of results and dissemination of findings to relevant audiences. Findings from this research will characterize gaps in access to MOUD that, if addressed, can substantially improve public health and well-being. The training and mentoring plans will build skills and expertise in (1) legal epidemiology methods to code and analyze waivers (Aim 1), (2) advanced causal inference methods using real-world Medicaid claims data and content expertise on opioid use disorders treatment to measure the impact of waivers on outcomes (Aim 2), (3) community-engaged and mixed methods approaches to investigate the implementation of waivers and to triangulate data from quantitative and qualitative aims guided by the perspective of stakeholders. This award will provide a platform to launch an independent research program that will fill a critical gap in knowledge about interventions to scale up MOUD use.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $186,994 )
2026	2026	TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION	1805 N BROAD ST	PHILADELPHIA	PA	19122	PHILADELPHIA	USA	Drug Use and Addiction Research Programs	000	2	7/30/2026	NON-COMPETING CONTINUATION	$186,994
														Subtotal = $186,994

Issue Date FY: 2025 ( Subtotal = $187,164 )
2025	2025	TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION	1805 N BROAD ST	PHILADELPHIA	PA	19122	PHILADELPHIA	USA	Drug Use and Addiction Research Programs	000	1	5/22/2025	NEW	$187,164
														Subtotal = $187,164

Grand Total All Awards = $374,158

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Impact of "Institutions for Mental Diseases" Medicaid waivers on opioid use disorder treatment: a mixed methods approach to improve utilization of Medications for Opioid Use Disorders

Award Number: K01DA061053

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 06/01/2025

PERIOD OF PERFORMANCE END DATE: 05/31/2030

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer